This study suggests that BMSCs‐Exos regulate the TRIM24/CBP/STAT6 axis via miR‐137‐3p delivery and targeting the TRIM24‐STAT6 acetylation pathway may provide a promising therapeutic strategy for ALI. Here, TRIM24 is linked to acute respiratory distress syndrome.